Development and validation of monoclonal antibodies specific for Candida albicans Als2, Als9-1, and Als9-2. Oh SH, Coleman DA, Zhao X, Hoyer LL, et al. PLoS One 2022;17:e0269681.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oh SH, Coleman DA, Zhao X, Hoyer LL, et al. Development and validation of monoclonal antibodies specific for Candida albicans Als2, Als9-1, and Als9-2. PLoS One 2022;17:e0269681.
PMID: 35802580